GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Name | miRBASE accession |
---|---|
hsa-let-7a-5p
|
MIMAT0000062 |
hsa-let-7b-5p
|
MIMAT0000063 |
hsa-let-7c-5p
|
MIMAT0000064 |
hsa-let-7d-5p
|
MIMAT0000065 |
hsa-let-7e-5p
|
MIMAT0000066 |
hsa-let-7f-5p
|
MIMAT0000067 |
hsa-let-7g-5p
|
MIMAT0000414 |
hsa-let-7i-5p
|
MIMAT0000415 |
hsa-miR-98-5p
|
MIMAT0000096 |
hsa-miR-4458
|
MIMAT0018980 |
hsa-miR-4500
|
MIMAT0019036 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_204380919 | 66.68 |
ENST00000367188.4
|
PPP1R15B
|
protein phosphatase 1, regulatory subunit 15B |
chr18_+_21693306 | 50.94 |
ENST00000540918.2
|
TTC39C
|
tetratricopeptide repeat domain 39C |
chr13_-_30881621 | 45.76 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
chr5_-_131132614 | 43.13 |
ENST00000307968.7
ENST00000307954.8 |
FNIP1
|
folliculin interacting protein 1 |
chr19_+_56915668 | 34.52 |
ENST00000333201.9
ENST00000391778.3 |
ZNF583
|
zinc finger protein 583 |
chr7_+_94023873 | 33.94 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
chrX_-_54384425 | 28.18 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr15_+_74833518 | 26.32 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chrX_+_56259316 | 25.32 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
chr15_-_45670924 | 25.16 |
ENST00000396659.3
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr7_-_44924939 | 24.75 |
ENST00000395699.2
|
PURB
|
purine-rich element binding protein B |
chr11_+_113930291 | 24.64 |
ENST00000335953.4
|
ZBTB16
|
zinc finger and BTB domain containing 16 |
chr1_-_179846928 | 24.13 |
ENST00000367612.3
ENST00000609928.1 |
TOR1AIP2
|
torsin A interacting protein 2 |
chr2_-_37193606 | 23.90 |
ENST00000379213.2
ENST00000263918.4 |
STRN
|
striatin, calmodulin binding protein |
chr9_+_101705893 | 23.67 |
ENST00000375001.3
|
COL15A1
|
collagen, type XV, alpha 1 |
chr20_-_48532019 | 22.36 |
ENST00000289431.5
|
SPATA2
|
spermatogenesis associated 2 |
chr15_+_45879321 | 22.32 |
ENST00000220531.3
ENST00000567461.1 |
BLOC1S6
|
biogenesis of lysosomal organelles complex-1, subunit 6, pallidin |
chr16_+_66914264 | 21.64 |
ENST00000311765.2
ENST00000568869.1 ENST00000561704.1 ENST00000568398.1 ENST00000566776.1 |
PDP2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
chr5_-_172198190 | 21.10 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr1_-_92351769 | 21.01 |
ENST00000212355.4
|
TGFBR3
|
transforming growth factor, beta receptor III |
chr6_+_71122974 | 20.88 |
ENST00000418814.2
|
FAM135A
|
family with sequence similarity 135, member A |
chr14_-_74551172 | 20.68 |
ENST00000553458.1
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1 |
chr2_+_70142189 | 19.33 |
ENST00000264444.2
|
MXD1
|
MAX dimerization protein 1 |
chr12_+_4918342 | 19.26 |
ENST00000280684.3
ENST00000433855.1 |
KCNA6
|
potassium voltage-gated channel, shaker-related subfamily, member 6 |
chr2_+_189839046 | 19.23 |
ENST00000304636.3
ENST00000317840.5 |
COL3A1
|
collagen, type III, alpha 1 |
chr3_-_57678772 | 19.03 |
ENST00000311128.5
|
DENND6A
|
DENN/MADD domain containing 6A |
chr20_+_49348081 | 18.29 |
ENST00000371610.2
|
PARD6B
|
par-6 family cell polarity regulator beta |
chr11_+_119076745 | 18.16 |
ENST00000264033.4
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase |
chr5_-_159739532 | 17.69 |
ENST00000520748.1
ENST00000393977.3 ENST00000257536.7 |
CCNJL
|
cyclin J-like |
chr7_+_138916231 | 17.69 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
chr1_-_118472216 | 17.50 |
ENST00000369443.5
|
GDAP2
|
ganglioside induced differentiation associated protein 2 |
chr2_-_206950781 | 17.36 |
ENST00000403263.1
|
INO80D
|
INO80 complex subunit D |
chr1_+_203274639 | 17.35 |
ENST00000290551.4
|
BTG2
|
BTG family, member 2 |
chr12_-_42538657 | 17.11 |
ENST00000398675.3
|
GXYLT1
|
glucoside xylosyltransferase 1 |
chr8_+_22102626 | 17.07 |
ENST00000519237.1
ENST00000397802.4 |
POLR3D
|
polymerase (RNA) III (DNA directed) polypeptide D, 44kDa |
chr9_-_127533519 | 16.98 |
ENST00000487099.2
ENST00000344523.4 ENST00000373584.3 |
NR6A1
|
nuclear receptor subfamily 6, group A, member 1 |
chr12_-_111021110 | 16.88 |
ENST00000354300.3
|
PPTC7
|
PTC7 protein phosphatase homolog (S. cerevisiae) |
chr17_+_36508111 | 16.83 |
ENST00000331159.5
ENST00000577233.1 |
SOCS7
|
suppressor of cytokine signaling 7 |
chr11_+_45868957 | 16.71 |
ENST00000443527.2
|
CRY2
|
cryptochrome 2 (photolyase-like) |
chr19_-_36980455 | 16.60 |
ENST00000454319.1
ENST00000392170.2 |
ZNF566
|
zinc finger protein 566 |
chr1_-_207224307 | 16.52 |
ENST00000315927.4
|
YOD1
|
YOD1 deubiquitinase |
chr4_+_128554081 | 16.49 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
chr3_-_170303845 | 16.38 |
ENST00000231706.5
|
SLC7A14
|
solute carrier family 7, member 14 |
chr15_-_83316254 | 16.33 |
ENST00000567678.1
ENST00000450751.2 |
CPEB1
|
cytoplasmic polyadenylation element binding protein 1 |
chr16_+_70148230 | 16.03 |
ENST00000398122.3
ENST00000568530.1 |
PDPR
|
pyruvate dehydrogenase phosphatase regulatory subunit |
chr6_+_56954867 | 15.87 |
ENST00000370708.4
ENST00000370702.1 |
ZNF451
|
zinc finger protein 451 |
chr8_+_24772455 | 15.81 |
ENST00000433454.2
|
NEFM
|
neurofilament, medium polypeptide |
chr1_+_41249539 | 15.51 |
ENST00000347132.5
ENST00000509682.2 |
KCNQ4
|
potassium voltage-gated channel, KQT-like subfamily, member 4 |
chr4_+_83821835 | 15.50 |
ENST00000302236.5
|
THAP9
|
THAP domain containing 9 |
chrX_+_16804544 | 15.49 |
ENST00000380122.5
ENST00000398155.4 |
TXLNG
|
taxilin gamma |
chr14_+_57857262 | 15.46 |
ENST00000555166.1
ENST00000556492.1 ENST00000554703.1 |
NAA30
|
N(alpha)-acetyltransferase 30, NatC catalytic subunit |
chr19_+_4007644 | 15.46 |
ENST00000262971.2
|
PIAS4
|
protein inhibitor of activated STAT, 4 |
chr2_+_148602058 | 15.43 |
ENST00000241416.7
ENST00000535787.1 ENST00000404590.1 |
ACVR2A
|
activin A receptor, type IIA |
chr5_+_157170703 | 15.42 |
ENST00000286307.5
|
LSM11
|
LSM11, U7 small nuclear RNA associated |
chr12_+_69864129 | 15.34 |
ENST00000547219.1
ENST00000299293.2 ENST00000549921.1 ENST00000550316.1 ENST00000548154.1 ENST00000547414.1 ENST00000550389.1 ENST00000550937.1 ENST00000549092.1 ENST00000550169.1 |
FRS2
|
fibroblast growth factor receptor substrate 2 |
chr10_+_14920843 | 15.33 |
ENST00000433779.1
ENST00000378325.3 ENST00000354919.6 ENST00000313519.5 ENST00000420416.1 |
SUV39H2
|
suppressor of variegation 3-9 homolog 2 (Drosophila) |
chr1_+_60280458 | 15.02 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
chr1_-_153363452 | 14.89 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr15_-_51630772 | 14.85 |
ENST00000557858.1
ENST00000558328.1 ENST00000396404.4 ENST00000561075.1 ENST00000405011.2 ENST00000559980.1 ENST00000453807.2 ENST00000396402.1 |
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1 |
chr10_-_75571341 | 14.85 |
ENST00000309979.6
|
NDST2
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2 |
chr4_-_174451370 | 14.82 |
ENST00000359562.4
|
HAND2
|
heart and neural crest derivatives expressed 2 |
chr17_-_61777459 | 14.76 |
ENST00000578993.1
ENST00000583211.1 ENST00000259006.3 |
LIMD2
|
LIM domain containing 2 |
chr12_-_93323013 | 14.70 |
ENST00000322349.8
|
EEA1
|
early endosome antigen 1 |
chr8_-_48651648 | 14.65 |
ENST00000408965.3
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta |
chr19_+_46800289 | 14.59 |
ENST00000377670.4
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit |
chr9_+_99212403 | 14.47 |
ENST00000375251.3
ENST00000375249.4 |
HABP4
|
hyaluronan binding protein 4 |
chr19_-_7293942 | 14.38 |
ENST00000341500.5
ENST00000302850.5 |
INSR
|
insulin receptor |
chr1_+_19638788 | 14.17 |
ENST00000375155.3
ENST00000375153.3 ENST00000400548.2 |
PQLC2
|
PQ loop repeat containing 2 |
chr11_-_86666427 | 14.15 |
ENST00000531380.1
|
FZD4
|
frizzled family receptor 4 |
chr16_+_640055 | 13.99 |
ENST00000568586.1
ENST00000538492.1 ENST00000248139.3 |
RAB40C
|
RAB40C, member RAS oncogene family |
chr3_+_57541975 | 13.97 |
ENST00000487257.1
ENST00000311180.8 |
PDE12
|
phosphodiesterase 12 |
chr3_-_53080047 | 13.92 |
ENST00000482396.1
ENST00000358080.2 ENST00000296295.6 ENST00000394752.3 |
SFMBT1
|
Scm-like with four mbt domains 1 |
chr7_-_123389104 | 13.81 |
ENST00000223023.4
|
WASL
|
Wiskott-Aldrich syndrome-like |
chr17_+_29718642 | 13.61 |
ENST00000325874.8
|
RAB11FIP4
|
RAB11 family interacting protein 4 (class II) |
chr19_+_45582453 | 13.60 |
ENST00000591607.1
ENST00000591747.1 ENST00000270257.4 ENST00000391951.2 ENST00000587566.1 |
GEMIN7
MARK4
|
gem (nuclear organelle) associated protein 7 MAP/microtubule affinity-regulating kinase 4 |
chr7_+_108210012 | 13.50 |
ENST00000249356.3
|
DNAJB9
|
DnaJ (Hsp40) homolog, subfamily B, member 9 |
chr2_+_128848881 | 13.50 |
ENST00000259253.6
|
UGGT1
|
UDP-glucose glycoprotein glucosyltransferase 1 |
chr17_+_8213590 | 13.28 |
ENST00000361926.3
|
ARHGEF15
|
Rho guanine nucleotide exchange factor (GEF) 15 |
chr5_+_56111361 | 13.09 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
chr14_+_74111578 | 13.06 |
ENST00000554113.1
ENST00000555631.2 ENST00000553645.2 ENST00000311089.3 ENST00000555919.3 ENST00000554339.1 ENST00000554871.1 |
DNAL1
|
dynein, axonemal, light chain 1 |
chr18_-_74207146 | 12.96 |
ENST00000443185.2
|
ZNF516
|
zinc finger protein 516 |
chr5_-_32313019 | 12.88 |
ENST00000280285.5
ENST00000264934.5 |
MTMR12
|
myotubularin related protein 12 |
chr3_+_49591881 | 12.85 |
ENST00000296452.4
|
BSN
|
bassoon presynaptic cytomatrix protein |
chr22_+_29469012 | 12.85 |
ENST00000400335.4
ENST00000400338.2 |
KREMEN1
|
kringle containing transmembrane protein 1 |
chr20_+_57267669 | 12.80 |
ENST00000356091.6
|
NPEPL1
|
aminopeptidase-like 1 |
chr7_+_20370746 | 12.72 |
ENST00000222573.4
|
ITGB8
|
integrin, beta 8 |
chr21_-_28217721 | 12.50 |
ENST00000284984.3
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
chr5_-_153857819 | 12.35 |
ENST00000231121.2
|
HAND1
|
heart and neural crest derivatives expressed 1 |
chr9_-_73029540 | 12.35 |
ENST00000377126.2
|
KLF9
|
Kruppel-like factor 9 |
chr14_-_75593708 | 12.33 |
ENST00000557673.1
ENST00000238616.5 |
NEK9
|
NIMA-related kinase 9 |
chr1_-_115880852 | 12.21 |
ENST00000369512.2
|
NGF
|
nerve growth factor (beta polypeptide) |
chr19_+_1752372 | 12.07 |
ENST00000382349.4
|
ONECUT3
|
one cut homeobox 3 |
chr4_+_75858290 | 12.06 |
ENST00000513238.1
|
PARM1
|
prostate androgen-regulated mucin-like protein 1 |
chr1_-_182573514 | 11.99 |
ENST00000367558.5
|
RGS16
|
regulator of G-protein signaling 16 |
chr12_-_89918522 | 11.95 |
ENST00000529983.2
|
GALNT4
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) |
chr2_+_16080659 | 11.90 |
ENST00000281043.3
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog |
chr12_-_69326940 | 11.88 |
ENST00000549781.1
ENST00000548262.1 ENST00000551568.1 ENST00000548954.1 |
CPM
|
carboxypeptidase M |
chr11_-_72145669 | 11.88 |
ENST00000543042.1
ENST00000294053.3 |
CLPB
|
ClpB caseinolytic peptidase B homolog (E. coli) |
chr7_-_138666053 | 11.88 |
ENST00000440172.1
ENST00000422774.1 |
KIAA1549
|
KIAA1549 |
chr3_+_38495333 | 11.84 |
ENST00000352511.4
|
ACVR2B
|
activin A receptor, type IIB |
chr17_+_64961026 | 11.75 |
ENST00000262138.3
|
CACNG4
|
calcium channel, voltage-dependent, gamma subunit 4 |
chr10_+_101419187 | 11.74 |
ENST00000370489.4
|
ENTPD7
|
ectonucleoside triphosphate diphosphohydrolase 7 |
chr2_+_177053307 | 11.73 |
ENST00000331462.4
|
HOXD1
|
homeobox D1 |
chr12_-_42632016 | 11.72 |
ENST00000442791.3
ENST00000327791.4 ENST00000534854.2 ENST00000380788.3 ENST00000380790.4 |
YAF2
|
YY1 associated factor 2 |
chr12_-_89919965 | 11.69 |
ENST00000548729.1
|
POC1B-GALNT4
|
POC1B-GALNT4 readthrough |
chr11_+_76571911 | 11.67 |
ENST00000534206.1
ENST00000532485.1 ENST00000526597.1 ENST00000533873.1 ENST00000538157.1 |
ACER3
|
alkaline ceramidase 3 |
chr5_+_65018017 | 11.66 |
ENST00000380985.5
ENST00000502464.1 |
NLN
|
neurolysin (metallopeptidase M3 family) |
chr13_-_52733980 | 11.65 |
ENST00000339406.3
|
NEK3
|
NIMA-related kinase 3 |
chr1_+_57110972 | 11.61 |
ENST00000371244.4
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit |
chr6_+_106546808 | 11.59 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr8_-_134584152 | 11.57 |
ENST00000521180.1
ENST00000517668.1 ENST00000319914.5 |
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
chr11_-_74109422 | 11.54 |
ENST00000298198.4
|
PGM2L1
|
phosphoglucomutase 2-like 1 |
chr14_+_24867992 | 11.44 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr3_-_185216766 | 11.34 |
ENST00000296254.3
|
TMEM41A
|
transmembrane protein 41A |
chr14_-_52535712 | 11.34 |
ENST00000216286.5
ENST00000541773.1 |
NID2
|
nidogen 2 (osteonidogen) |
chr5_+_131993856 | 11.21 |
ENST00000304506.3
|
IL13
|
interleukin 13 |
chr6_+_41606176 | 11.15 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
chrX_+_21857717 | 11.05 |
ENST00000379484.5
|
MBTPS2
|
membrane-bound transcription factor peptidase, site 2 |
chr6_-_35464727 | 11.05 |
ENST00000402886.3
|
TEAD3
|
TEA domain family member 3 |
chr17_+_77751931 | 11.04 |
ENST00000310942.4
ENST00000269399.5 |
CBX2
|
chromobox homolog 2 |
chr6_-_26659913 | 11.04 |
ENST00000480036.1
ENST00000415922.2 |
ZNF322
|
zinc finger protein 322 |
chr7_-_6312206 | 10.95 |
ENST00000350796.3
|
CYTH3
|
cytohesin 3 |
chr18_+_55102917 | 10.81 |
ENST00000491143.2
|
ONECUT2
|
one cut homeobox 2 |
chr5_-_74326724 | 10.76 |
ENST00000322348.4
|
GCNT4
|
glucosaminyl (N-acetyl) transferase 4, core 2 |
chr1_-_179198702 | 10.71 |
ENST00000502732.1
|
ABL2
|
c-abl oncogene 2, non-receptor tyrosine kinase |
chr4_+_88571429 | 10.54 |
ENST00000339673.6
ENST00000282479.7 |
DMP1
|
dentin matrix acidic phosphoprotein 1 |
chr17_-_58469474 | 10.53 |
ENST00000300896.4
|
USP32
|
ubiquitin specific peptidase 32 |
chr16_+_2479390 | 10.50 |
ENST00000397066.4
|
CCNF
|
cyclin F |
chr1_+_113615794 | 10.37 |
ENST00000361127.5
|
LRIG2
|
leucine-rich repeats and immunoglobulin-like domains 2 |
chr19_+_50528971 | 10.30 |
ENST00000598809.1
ENST00000595661.1 ENST00000391821.2 |
ZNF473
|
zinc finger protein 473 |
chr1_-_204121013 | 10.29 |
ENST00000367201.3
|
ETNK2
|
ethanolamine kinase 2 |
chr7_+_76090993 | 10.28 |
ENST00000425780.1
ENST00000456590.1 ENST00000451769.1 ENST00000324432.5 ENST00000307569.8 ENST00000457529.1 ENST00000446600.1 ENST00000413936.2 ENST00000423646.1 ENST00000438930.1 ENST00000430490.2 |
DTX2
|
deltex homolog 2 (Drosophila) |
chr15_-_45815005 | 10.27 |
ENST00000261867.4
|
SLC30A4
|
solute carrier family 30 (zinc transporter), member 4 |
chr9_-_16870704 | 10.25 |
ENST00000380672.4
ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2
|
basonuclin 2 |
chr16_+_81348528 | 10.17 |
ENST00000568107.2
|
GAN
|
gigaxonin |
chr5_-_132948216 | 10.11 |
ENST00000265342.7
|
FSTL4
|
follistatin-like 4 |
chr4_+_56815102 | 10.09 |
ENST00000257287.4
|
CEP135
|
centrosomal protein 135kDa |
chr10_+_115803650 | 10.07 |
ENST00000369295.2
|
ADRB1
|
adrenoceptor beta 1 |
chr10_-_50747064 | 9.98 |
ENST00000355832.5
ENST00000603152.1 ENST00000447839.2 |
ERCC6
PGBD3
ERCC6-PGBD3
|
excision repair cross-complementing rodent repair deficiency, complementation group 6 piggyBac transposable element derived 3 ERCC6-PGBD3 readthrough |
chr14_+_105781048 | 9.92 |
ENST00000458164.2
ENST00000447393.1 |
PACS2
|
phosphofurin acidic cluster sorting protein 2 |
chr12_+_103981044 | 9.91 |
ENST00000388887.2
|
STAB2
|
stabilin 2 |
chr5_+_176560742 | 9.85 |
ENST00000439151.2
|
NSD1
|
nuclear receptor binding SET domain protein 1 |
chr17_-_19771216 | 9.84 |
ENST00000395544.4
|
ULK2
|
unc-51 like autophagy activating kinase 2 |
chrX_+_118108571 | 9.64 |
ENST00000304778.7
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
chr9_-_77567743 | 9.61 |
ENST00000376854.5
|
C9orf40
|
chromosome 9 open reading frame 40 |
chr17_-_7197881 | 9.50 |
ENST00000007699.5
|
YBX2
|
Y box binding protein 2 |
chr1_-_9189229 | 9.46 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
chr9_+_118916082 | 9.42 |
ENST00000328252.3
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1 |
chr8_-_82024290 | 9.29 |
ENST00000220597.4
|
PAG1
|
phosphoprotein associated with glycosphingolipid microdomains 1 |
chr12_+_4382917 | 9.28 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
chr14_-_101036119 | 9.12 |
ENST00000355173.2
|
BEGAIN
|
brain-enriched guanylate kinase-associated |
chr5_-_139943830 | 9.11 |
ENST00000412920.3
ENST00000511201.2 ENST00000356738.2 ENST00000354402.5 ENST00000358580.5 ENST00000508496.2 |
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr17_-_4167142 | 9.06 |
ENST00000570535.1
ENST00000574367.1 ENST00000341657.4 ENST00000433651.1 |
ANKFY1
|
ankyrin repeat and FYVE domain containing 1 |
chrX_+_152907913 | 9.03 |
ENST00000370167.4
|
DUSP9
|
dual specificity phosphatase 9 |
chr13_-_114144998 | 8.97 |
ENST00000332592.3
ENST00000439909.2 ENST00000375399.2 |
DCUN1D2
|
DCN1, defective in cullin neddylation 1, domain containing 2 |
chr3_+_50712672 | 8.97 |
ENST00000266037.9
|
DOCK3
|
dedicator of cytokinesis 3 |
chr4_+_56212270 | 8.95 |
ENST00000264228.4
|
SRD5A3
|
steroid 5 alpha-reductase 3 |
chr8_-_37824442 | 8.93 |
ENST00000345060.3
|
ADRB3
|
adrenoceptor beta 3 |
chr12_+_94542459 | 8.92 |
ENST00000258526.4
|
PLXNC1
|
plexin C1 |
chr1_-_169863016 | 8.79 |
ENST00000367772.4
ENST00000367771.6 |
SCYL3
|
SCY1-like 3 (S. cerevisiae) |
chr9_+_102668915 | 8.72 |
ENST00000259400.6
ENST00000531035.1 ENST00000525640.1 ENST00000534052.1 ENST00000526607.1 |
STX17
|
syntaxin 17 |
chr1_-_115632035 | 8.63 |
ENST00000433172.1
ENST00000369514.2 ENST00000369516.2 ENST00000369515.2 |
TSPAN2
|
tetraspanin 2 |
chr19_+_47249302 | 8.58 |
ENST00000601299.1
ENST00000318584.5 ENST00000595570.1 ENST00000598271.1 ENST00000597313.1 ENST00000593875.1 ENST00000391909.3 ENST00000602250.1 ENST00000595868.1 ENST00000600629.1 ENST00000602181.1 ENST00000593800.1 ENST00000600227.1 ENST00000600005.1 ENST00000594467.1 ENST00000596460.1 |
FKRP
|
fukutin related protein |
chr9_+_136325089 | 8.57 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
chr3_+_119187785 | 8.52 |
ENST00000295588.4
ENST00000476573.1 |
POGLUT1
|
protein O-glucosyltransferase 1 |
chr10_+_104678032 | 8.51 |
ENST00000369878.4
ENST00000369875.3 |
CNNM2
|
cyclin M2 |
chr12_-_57400227 | 8.49 |
ENST00000300101.2
|
ZBTB39
|
zinc finger and BTB domain containing 39 |
chr2_+_219575543 | 8.41 |
ENST00000457313.1
ENST00000415717.1 ENST00000392102.1 |
TTLL4
|
tubulin tyrosine ligase-like family, member 4 |
chr9_-_72287191 | 8.39 |
ENST00000265381.4
|
APBA1
|
amyloid beta (A4) precursor protein-binding, family A, member 1 |
chrX_+_147582130 | 8.36 |
ENST00000370460.2
ENST00000370457.5 |
AFF2
|
AF4/FMR2 family, member 2 |
chr1_+_155829286 | 8.27 |
ENST00000368324.4
|
SYT11
|
synaptotagmin XI |
chr7_-_71801980 | 8.27 |
ENST00000329008.5
|
CALN1
|
calneuron 1 |
chr6_+_117002339 | 8.20 |
ENST00000413340.1
ENST00000368564.1 ENST00000356348.1 |
KPNA5
|
karyopherin alpha 5 (importin alpha 6) |
chr5_+_149109825 | 8.19 |
ENST00000360453.4
ENST00000394320.3 ENST00000309241.5 |
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
chr1_-_146644122 | 8.13 |
ENST00000254101.3
|
PRKAB2
|
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
chr1_-_23857698 | 8.07 |
ENST00000361729.2
|
E2F2
|
E2F transcription factor 2 |
chr10_-_94003003 | 8.06 |
ENST00000412050.4
|
CPEB3
|
cytoplasmic polyadenylation element binding protein 3 |
chr1_-_200992827 | 7.96 |
ENST00000332129.2
ENST00000422435.2 |
KIF21B
|
kinesin family member 21B |
chr8_-_98290087 | 7.95 |
ENST00000322128.3
|
TSPYL5
|
TSPY-like 5 |
chr17_-_58603568 | 7.91 |
ENST00000083182.3
|
APPBP2
|
amyloid beta precursor protein (cytoplasmic tail) binding protein 2 |
chr1_+_213123915 | 7.84 |
ENST00000366968.4
ENST00000490792.1 |
VASH2
|
vasohibin 2 |
chrX_+_49687216 | 7.76 |
ENST00000376088.3
|
CLCN5
|
chloride channel, voltage-sensitive 5 |
chr19_+_1450112 | 7.71 |
ENST00000590469.1
ENST00000233607.2 ENST00000238483.4 ENST00000590877.1 |
APC2
|
adenomatosis polyposis coli 2 |
chr8_-_93115445 | 7.68 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr1_-_157108130 | 7.67 |
ENST00000368192.4
|
ETV3
|
ets variant 3 |
chr22_-_31536480 | 7.60 |
ENST00000215885.3
|
PLA2G3
|
phospholipase A2, group III |
chr1_+_12227035 | 7.52 |
ENST00000376259.3
ENST00000536782.1 |
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B |
chr8_+_28351707 | 7.51 |
ENST00000537916.1
ENST00000523546.1 ENST00000240093.3 |
FZD3
|
frizzled family receptor 3 |
chr12_-_102874416 | 7.49 |
ENST00000392904.1
ENST00000337514.6 |
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr11_-_62389449 | 7.39 |
ENST00000534026.1
|
B3GAT3
|
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
chr6_+_138483058 | 7.39 |
ENST00000251691.4
|
KIAA1244
|
KIAA1244 |
chr11_-_10590238 | 7.39 |
ENST00000256178.3
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr10_+_102295616 | 7.34 |
ENST00000299163.6
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor |
chrX_+_95939711 | 7.30 |
ENST00000373049.4
ENST00000324765.8 |
DIAPH2
|
diaphanous-related formin 2 |
chr9_+_101867359 | 7.26 |
ENST00000374994.4
|
TGFBR1
|
transforming growth factor, beta receptor 1 |
chr6_-_8064567 | 7.22 |
ENST00000543936.1
ENST00000397457.2 |
BLOC1S5
|
biogenesis of lysosomal organelles complex-1, subunit 5, muted |
chr15_+_41952591 | 7.14 |
ENST00000566718.1
ENST00000219905.7 ENST00000389936.4 ENST00000545763.1 |
MGA
|
MGA, MAX dimerization protein |
chr12_+_72666407 | 7.03 |
ENST00000261180.4
|
TRHDE
|
thyrotropin-releasing hormone degrading enzyme |
chr16_-_11350036 | 7.01 |
ENST00000332029.2
|
SOCS1
|
suppressor of cytokine signaling 1 |
chr8_+_81397876 | 6.99 |
ENST00000430430.1
|
ZBTB10
|
zinc finger and BTB domain containing 10 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.9 | 43.8 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
7.6 | 45.8 | GO:0051013 | microtubule severing(GO:0051013) |
7.4 | 66.7 | GO:1903912 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
7.0 | 28.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
7.0 | 21.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
6.5 | 19.6 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
5.6 | 16.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
5.5 | 16.5 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
5.4 | 27.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
5.3 | 15.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
5.2 | 36.2 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
5.2 | 20.7 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
5.1 | 25.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
5.1 | 15.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
5.0 | 14.9 | GO:2000864 | negative regulation of macrophage chemotaxis(GO:0010760) estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
4.8 | 14.4 | GO:1990535 | neuron projection maintenance(GO:1990535) |
4.7 | 14.2 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
4.6 | 13.8 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
4.5 | 13.5 | GO:0097359 | UDP-glucosylation(GO:0097359) |
4.2 | 16.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
3.9 | 11.7 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
3.7 | 11.2 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
3.4 | 10.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
3.2 | 19.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
3.1 | 15.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
3.0 | 24.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
3.0 | 21.2 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
3.0 | 9.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
2.8 | 8.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
2.7 | 8.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
2.7 | 29.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
2.7 | 39.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
2.6 | 13.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
2.6 | 15.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
2.5 | 7.5 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
2.4 | 7.3 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
2.4 | 12.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
2.4 | 9.5 | GO:0009386 | translational attenuation(GO:0009386) |
2.4 | 7.1 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
2.3 | 6.8 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
2.2 | 26.9 | GO:0015074 | DNA integration(GO:0015074) |
2.2 | 6.7 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
2.2 | 15.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
2.1 | 29.5 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) positive regulation of pigment cell differentiation(GO:0050942) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
2.1 | 19.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
2.1 | 23.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
2.1 | 37.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
2.1 | 12.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
2.0 | 4.1 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
2.0 | 12.0 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.8 | 11.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
1.8 | 7.3 | GO:1905075 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
1.8 | 5.3 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) histone H3-K27 demethylation(GO:0071557) |
1.8 | 12.4 | GO:0051414 | response to cortisol(GO:0051414) |
1.7 | 8.7 | GO:0016240 | autophagosome docking(GO:0016240) |
1.7 | 19.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
1.7 | 8.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
1.7 | 13.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
1.6 | 6.4 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.6 | 9.7 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
1.6 | 11.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.6 | 3.1 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
1.5 | 4.6 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
1.5 | 9.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.5 | 9.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
1.5 | 10.5 | GO:0070166 | enamel mineralization(GO:0070166) |
1.5 | 7.5 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
1.5 | 4.5 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
1.5 | 11.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.4 | 8.6 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.4 | 9.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.4 | 9.8 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
1.4 | 5.6 | GO:1990936 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
1.4 | 8.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.4 | 7.0 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.4 | 2.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.3 | 10.8 | GO:0002118 | aggressive behavior(GO:0002118) |
1.3 | 4.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.3 | 16.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
1.3 | 3.9 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
1.3 | 6.5 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
1.3 | 3.8 | GO:1904954 | Spemann organizer formation(GO:0060061) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
1.3 | 16.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.3 | 3.8 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
1.3 | 3.8 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.3 | 7.6 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
1.2 | 14.8 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
1.2 | 13.6 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.2 | 1.2 | GO:0098923 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
1.2 | 8.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
1.2 | 3.6 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.2 | 14.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.2 | 6.0 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
1.2 | 4.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.2 | 11.7 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
1.2 | 17.3 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.2 | 10.4 | GO:0051045 | negative regulation of axon regeneration(GO:0048681) negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.1 | 3.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
1.1 | 4.5 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
1.1 | 16.5 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
1.1 | 6.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.1 | 13.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.1 | 16.3 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.1 | 3.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
1.1 | 6.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.1 | 3.2 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
1.1 | 3.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
1.1 | 8.4 | GO:0016926 | protein desumoylation(GO:0016926) |
1.0 | 1.0 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
1.0 | 4.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
1.0 | 19.7 | GO:0006853 | carnitine shuttle(GO:0006853) |
1.0 | 4.9 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
1.0 | 2.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.0 | 6.7 | GO:0050893 | sensory processing(GO:0050893) |
0.9 | 2.8 | GO:0032641 | negative regulation of tolerance induction(GO:0002644) lymphotoxin A production(GO:0032641) interleukin-4 biosynthetic process(GO:0042097) lymphotoxin A biosynthetic process(GO:0042109) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.9 | 8.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.9 | 11.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.9 | 4.4 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.9 | 3.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.9 | 11.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.9 | 7.7 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.9 | 11.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.8 | 3.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.8 | 12.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.8 | 0.8 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.8 | 4.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.8 | 11.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.8 | 8.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.8 | 7.0 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.8 | 8.5 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.8 | 3.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.8 | 12.8 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.7 | 3.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.7 | 1.5 | GO:1903365 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.7 | 20.6 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.7 | 11.7 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.7 | 4.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.7 | 10.2 | GO:0043586 | tongue development(GO:0043586) |
0.7 | 2.2 | GO:0002384 | hepatic immune response(GO:0002384) |
0.7 | 9.5 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.7 | 7.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.7 | 11.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.7 | 10.5 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.7 | 5.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 7.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.6 | 10.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.6 | 7.5 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.6 | 8.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.6 | 3.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 1.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.6 | 5.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.6 | 5.4 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.6 | 2.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.6 | 5.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.6 | 5.7 | GO:0015871 | choline transport(GO:0015871) |
0.5 | 10.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 6.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.5 | 5.9 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.5 | 1.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 4.8 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.5 | 16.8 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.5 | 2.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.5 | 4.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.5 | 2.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 5.0 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.5 | 6.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.5 | 10.8 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 9.4 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.4 | 13.0 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.4 | 14.7 | GO:0097576 | vacuole fusion(GO:0097576) |
0.4 | 5.6 | GO:0045008 | depyrimidination(GO:0045008) |
0.4 | 5.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.4 | 11.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 15.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.4 | 14.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 1.6 | GO:0015853 | adenine transport(GO:0015853) |
0.4 | 12.7 | GO:0007616 | long-term memory(GO:0007616) |
0.4 | 3.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 3.3 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) |
0.4 | 2.6 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.4 | 6.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.4 | 19.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.4 | 1.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 14.7 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.3 | 13.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 5.9 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
0.3 | 5.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.3 | 5.7 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.3 | 12.5 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.3 | 12.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.3 | 3.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 12.2 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.3 | 0.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.3 | 14.7 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.3 | 3.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 5.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 17.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.3 | 12.9 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 6.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 4.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 13.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 0.5 | GO:1903059 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.3 | 2.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 5.0 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.3 | 15.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 10.7 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.3 | 5.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 1.2 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.2 | 7.9 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 2.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 1.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 1.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 8.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 43.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.2 | 14.7 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 3.9 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 11.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 1.3 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.2 | 13.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 4.2 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 12.3 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 4.3 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.2 | 11.9 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 17.5 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.2 | 6.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.2 | 6.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 2.0 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.2 | 11.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 3.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.2 | 1.4 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.2 | 1.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 5.3 | GO:0009306 | protein secretion(GO:0009306) |
0.2 | 8.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.1 | 16.4 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 2.2 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 8.2 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.1 | 7.3 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 1.2 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 9.1 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 2.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 1.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 1.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 8.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 5.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 9.8 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 3.7 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 18.5 | GO:0007601 | visual perception(GO:0007601) |
0.1 | 4.4 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 2.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 4.1 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.1 | 9.1 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 3.0 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 6.9 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 3.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 4.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 4.7 | GO:0046847 | filopodium assembly(GO:0046847) |
0.1 | 2.3 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 6.7 | GO:0007030 | Golgi organization(GO:0007030) |
0.1 | 5.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 12.8 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 1.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 1.8 | GO:0060021 | palate development(GO:0060021) |
0.1 | 2.7 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.1 | GO:1902410 | unidimensional cell growth(GO:0009826) mitotic cytokinetic process(GO:1902410) |
0.0 | 1.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 2.9 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 1.9 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
0.0 | 1.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 1.7 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 4.1 | GO:0051726 | regulation of cell cycle(GO:0051726) |
0.0 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 5.4 | GO:0007155 | cell adhesion(GO:0007155) |
0.0 | 20.4 | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter(GO:0000122) |
0.0 | 1.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.0 | 1.9 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.0 | 0.1 | GO:0071233 | cellular response to leucine(GO:0071233) cellular response to leucine starvation(GO:1990253) |
0.0 | 0.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 1.8 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) negative regulation of nuclear division(GO:0051784) |
0.0 | 0.4 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 1.3 | GO:0007416 | synapse assembly(GO:0007416) |
0.0 | 1.0 | GO:0007626 | locomotory behavior(GO:0007626) |
0.0 | 0.2 | GO:0044070 | regulation of anion transport(GO:0044070) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.1 | 36.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
4.2 | 12.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
3.9 | 66.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
3.9 | 15.5 | GO:0031417 | NatC complex(GO:0031417) |
3.8 | 15.0 | GO:0070695 | FHF complex(GO:0070695) |
3.7 | 44.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
2.9 | 14.7 | GO:0044308 | axonal spine(GO:0044308) |
2.9 | 14.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.6 | 25.9 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
1.9 | 11.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.9 | 15.4 | GO:0005683 | U7 snRNP(GO:0005683) |
1.8 | 9.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.7 | 13.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.7 | 8.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.7 | 24.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
1.6 | 29.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
1.6 | 13.1 | GO:0036157 | outer dynein arm(GO:0036157) |
1.5 | 9.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.4 | 18.2 | GO:0016600 | flotillin complex(GO:0016600) |
1.3 | 24.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.2 | 3.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
1.1 | 13.3 | GO:0030425 | dendrite(GO:0030425) |
1.1 | 8.6 | GO:0043196 | varicosity(GO:0043196) |
1.1 | 15.8 | GO:0005883 | neurofilament(GO:0005883) |
1.0 | 20.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.0 | 8.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.0 | 7.7 | GO:0016342 | catenin complex(GO:0016342) |
0.9 | 13.8 | GO:0030478 | actin cap(GO:0030478) |
0.8 | 7.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.8 | 11.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.8 | 3.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.8 | 2.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.8 | 3.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.7 | 9.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.7 | 2.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.7 | 17.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.6 | 1.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.6 | 4.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.6 | 20.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.6 | 14.4 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.6 | 3.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.6 | 1.7 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.6 | 5.0 | GO:0016013 | syntrophin complex(GO:0016013) |
0.5 | 2.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.5 | 2.6 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.5 | 3.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.5 | 3.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.5 | 21.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 25.3 | GO:0016235 | aggresome(GO:0016235) |
0.5 | 5.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 11.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 6.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 1.3 | GO:0031213 | RSF complex(GO:0031213) |
0.4 | 3.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.4 | 50.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.4 | 8.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 2.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 3.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 8.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 43.5 | GO:0016605 | PML body(GO:0016605) |
0.3 | 2.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 3.8 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 1.2 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.3 | 7.9 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 2.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 3.2 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 3.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 6.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 37.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.3 | 23.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 18.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.3 | 5.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 21.8 | GO:0005814 | centriole(GO:0005814) |
0.3 | 8.6 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 14.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 10.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 16.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 22.4 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 5.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 10.3 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 29.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 16.8 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 2.3 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 4.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.3 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 15.9 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.2 | 20.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 15.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 8.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 3.7 | GO:0035579 | specific granule membrane(GO:0035579) |
0.2 | 6.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 11.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 4.7 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 8.0 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 4.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 9.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 2.5 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 53.4 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 11.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 19.4 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 0.7 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 10.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 4.4 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 23.7 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 18.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 30.9 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 4.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 11.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 41.9 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 4.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 6.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 12.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 1.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 20.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 14.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 6.8 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 4.4 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 3.9 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.1 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 11.4 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 5.7 | GO:0030424 | axon(GO:0030424) |
0.0 | 17.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 4.2 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 3.1 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 4.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 3.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 1.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 25.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 5.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 5.9 | GO:0005667 | transcription factor complex(GO:0005667) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.8 | 43.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
7.6 | 45.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
6.5 | 19.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
6.3 | 37.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
6.3 | 31.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
6.2 | 31.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
5.5 | 16.5 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
5.1 | 15.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
5.0 | 14.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
4.8 | 14.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
4.8 | 67.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
4.7 | 14.2 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
4.5 | 13.5 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
4.3 | 30.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
3.9 | 15.5 | GO:0004803 | transposase activity(GO:0004803) |
3.9 | 11.6 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
3.7 | 14.8 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
3.6 | 14.4 | GO:0043559 | insulin binding(GO:0043559) |
3.6 | 10.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
3.3 | 9.8 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
3.1 | 15.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
3.0 | 9.0 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
2.9 | 11.7 | GO:0017040 | ceramidase activity(GO:0017040) |
2.9 | 8.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.8 | 28.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
2.6 | 28.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
2.6 | 28.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.5 | 12.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.2 | 20.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
2.1 | 8.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
2.0 | 5.9 | GO:0070052 | collagen V binding(GO:0070052) |
1.9 | 11.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.8 | 18.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.8 | 5.4 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
1.8 | 5.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.7 | 7.0 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
1.7 | 8.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
1.7 | 6.7 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
1.6 | 4.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.5 | 23.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.5 | 24.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.5 | 16.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
1.4 | 10.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.4 | 4.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.4 | 5.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.3 | 5.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
1.3 | 3.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
1.2 | 6.0 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
1.2 | 23.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.2 | 15.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.2 | 8.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.1 | 25.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
1.1 | 4.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.1 | 2.2 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
1.0 | 7.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
1.0 | 5.2 | GO:0043532 | angiostatin binding(GO:0043532) |
1.0 | 5.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.9 | 5.7 | GO:0039552 | RIG-I binding(GO:0039552) |
0.9 | 4.7 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.9 | 21.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.9 | 15.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.9 | 11.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.9 | 13.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 19.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.8 | 20.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.8 | 14.9 | GO:0070330 | aromatase activity(GO:0070330) |
0.8 | 23.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.8 | 11.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.8 | 4.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.8 | 3.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) ceramide binding(GO:0097001) |
0.8 | 3.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.8 | 2.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.8 | 12.2 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.8 | 7.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.8 | 9.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.7 | 17.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.7 | 8.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.7 | 6.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.7 | 7.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.7 | 23.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 15.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.7 | 13.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 13.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.7 | 3.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.7 | 13.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.7 | 3.9 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.6 | 6.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 14.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.6 | 4.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.6 | 4.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.5 | 3.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 10.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.5 | 7.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 57.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.5 | 5.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.5 | 6.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.5 | 4.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 6.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.5 | 3.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.4 | 7.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.4 | 3.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.4 | 6.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 0.4 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.4 | 4.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.4 | 2.6 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 15.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.4 | 5.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 18.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 10.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 39.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.4 | 10.0 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 1.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.4 | 4.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 1.6 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.4 | 14.8 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 3.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 6.7 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 7.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 7.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 62.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.4 | 19.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 10.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 3.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 10.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 26.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.3 | 3.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 1.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 7.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 34.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.3 | 34.1 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.3 | 9.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 5.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 2.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 3.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 10.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.3 | 5.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 10.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 25.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 7.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 5.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 17.9 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.2 | 17.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 6.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 1.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 11.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 1.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 5.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 3.3 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 6.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 6.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 2.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 3.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 11.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 3.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 57.3 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.2 | 6.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 10.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.2 | 1.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 5.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 3.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 1.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 3.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 4.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 2.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.7 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 17.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 1.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 3.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 9.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 17.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 1.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 3.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 8.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 2.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 4.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 6.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 18.0 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 27.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 7.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 12.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 5.1 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 5.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 4.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 2.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 12.2 | GO:0005126 | cytokine receptor binding(GO:0005126) |
0.1 | 0.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 2.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 1.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 3.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 3.2 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.3 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 1.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 17.9 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 1.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 2.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 2.1 | GO:0008047 | enzyme activator activity(GO:0008047) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.6 | 75.8 | NABA COLLAGENS | Genes encoding collagen proteins |
1.1 | 11.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.0 | 30.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.0 | 58.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.9 | 3.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.8 | 34.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.7 | 16.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.6 | 5.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 9.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 6.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 12.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.5 | 8.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 28.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 12.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 13.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.4 | 20.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.4 | 15.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 19.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 15.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 13.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 14.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 16.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.4 | 11.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 14.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 18.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 15.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 14.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.4 | 6.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 7.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 5.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 9.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 2.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 3.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 15.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 13.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 25.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 7.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 7.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 10.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.2 | 19.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 2.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 6.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 6.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 6.9 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 3.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 6.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 3.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 3.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 3.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 20.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 3.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 8.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 1.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 2.2 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 7.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 10.1 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 3.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 39.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.2 | 37.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.6 | 25.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.2 | 20.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.1 | 22.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.1 | 20.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.1 | 4.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.0 | 9.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.9 | 5.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.9 | 17.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.9 | 25.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.8 | 40.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.8 | 12.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.8 | 17.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.8 | 20.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.7 | 17.1 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.7 | 11.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.7 | 15.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.7 | 8.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.6 | 11.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 10.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 16.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.6 | 11.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.6 | 35.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 11.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 9.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.5 | 11.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 26.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 4.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.5 | 21.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.5 | 18.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.5 | 18.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 5.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 10.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 19.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 7.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 7.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 18.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 16.6 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.4 | 5.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 9.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 12.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.4 | 11.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 4.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 9.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 14.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 18.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.3 | 11.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 6.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 3.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 7.6 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.3 | 9.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 5.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 3.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 21.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 3.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 5.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 11.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 2.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 2.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 5.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 50.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 6.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 7.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 17.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 5.9 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.2 | 4.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 3.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 10.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 6.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 2.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 2.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 3.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 8.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 24.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 5.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 4.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 2.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 6.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 5.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.6 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 2.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 1.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 6.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 4.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 2.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |